Latest News about JNJ
Recent news which mentions JNJ
Tight budget this Giving Tuesday? Try these 7 tips to maximize donations — including channeling MacKenzie Scott
November 29, 2022
From MarketWatch
Will the Nasdaq or S&P 500 Have a Better 2023?
November 28, 2022
From Motley Fool
3 Dividend Stocks to Hold Forever
November 26, 2022
From Motley Fool
From Benzinga
2 Safe Dividend Stocks to Buy Hand Over Fist
November 23, 2022
From Motley Fool
2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
November 22, 2022
From Motley Fool
7 Must-Own Safe Havens as Market Selloff Accelerates
November 21, 2022
From InvestorPlace
2 Reasons to Buy Pfizer and 1 Reason to Sell
November 20, 2022
From Motley Fool
From Motley Fool
Bear Market Blues? 3 of the Best Stocks to Own in 2023
November 19, 2022
From Motley Fool
Analyst Expects Derisking Required Ahead Of Patent Expiry For This Large Pharma/MedTech Stock
November 18, 2022
Tickers
JNJ
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 17, 2022
From Benzinga
Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say
November 15, 2022
From Benzinga
World's Largest Hedge Fund Saw 32% Returns First Half Of 2022 — Check Out 3 Dividend Stocks Recently Purchased
November 14, 2022
From Benzinga
Flu Season Starts At Its Fastest Pace Since 2009 — Canada And Parts Of The U.S. Are Now Facing A Tylenol, Advil Shortage
November 14, 2022
Tickers
JNJ
From Benzinga
3 Dow Stocks You Can Buy Without Any Hesitation
November 12, 2022
From Motley Fool
These 2 Dividend Paying ETFs Have A Track Record For Increasing Payments, Can Help Diversify Against Industry Risk
November 11, 2022
From Benzinga
Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows
November 11, 2022
From Benzinga
2 Warren Buffett Passive Income Stocks You Can Buy to Boost Your Yield
November 11, 2022
From Motley Fool
Better Buy: Johnson & Johnson vs. Abbott Laboratories
November 10, 2022
From Motley Fool
From Motley Fool
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
November 10, 2022
From Benzinga
2 Healthcare Stocks That Could Help Make You a Fortune
November 10, 2022
From Motley Fool
3 Safe Dividend Stocks to Beat Inflation
November 10, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.